DRUGS AND NEONATAL JAUNDICE.
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000740:Anemia; D000743:Anemia, Hemolytic / Q000139:chemically induced*; D000962:Antimalarials; D058633:Antipyretics; D004899:Erythroblastosis, Fetal; D005260:Female; D005315:Fetal Diseases; D005955:Glucosephosphate Dehydrogenase Deficiency; D005958:Glucosephosphates; D006801:Humans; D006932:Hyperbilirubinemia; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D007565:Jaundice; D007567:Jaundice, Neonatal; D008431:Maternal-Fetal Exchange; D009657:North Carolina; D009675:Novobiocin; D011247:Pregnancy; D012459:Salicylates; D013444:Sulfisoxazole; D014116:Toxicology; D014812:Vitamin K
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000962:Antimalarials; D058633:Antipyretics; D005958:Glucosephosphates; D012459:Salicylates; D014812:Vitamin K; D009675:Novobiocin; D013444:Sulfisoxazole
ANALGESICS AND ANTIPYRETICS; ANEMIA, CHEMICAL INDUCED HEMOLYTIC; ANTIMALARIALS; ERYTHROBLASTOSIS, FETAL; FETAL DISEASES; GLUCOSEPHOSPHATE DEHY- DROGENASE DEFICIENCY; HYPERBILIRUBINEMIA; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; JAUNDICE, NEONATAL; MATERNAL-FETAL EXCHANGE; NOVOBIOCIN; PREGNANCY; SALICYLATES; SULFISOXAZOLE; TOXICOLOGIC REPORT; VITAMIN K